Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Cancer Research and Treatment|April 30, 2025
Safety and Effectiveness of Eribulin in Patients with Advanced or Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes in Real-World Clinical Practice: A 6-Year Post-Marketing Surveillance Study in South KoreaYee Soo Chae, Kyung A Kwon, Moon Hee Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2021
Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyJae Ho Jeong, Jeong Eun Kim, Jin-Hee Ahn, et al.
Plos One|August 17, 2021
Significance of descriptive symptoms and signs and clinical parameters as predictors of neuropathic cancer painSun Kyung Baek, Sang Won Shin, Su-Jin Koh, et al.
Scientific Reports|November 24, 2024
Depression, performance status, and discontinued treatment mediate an association of curability belief with prognosis in advanced cancer patientsJe-Yeon Yun, Ju Youn Jung, Bhumsuk Keam, et al.
International Journal of Cancer|April 27, 2021
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancerHyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, et al.
BMC Medical Ethics|March 7, 2023
Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional studyHyeon-Su Im, Insook Lee, Shinmi Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2013
Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancerSang-Yeon Suh, Youn Seon Choi, Chang Hwan Yeom, et al.
Cancer Research and Treatment|April 11, 2025
Exploring Oncologists' Perspectives on the Early Integration of Specialty Palliative Care in Korea: Challenges, Needs, and Clinical ImplicationsShin Hye Yoo, Yu Jung Kim, Ye Sul Jeung, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 13, 2015
Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV studyYoung Mi Seol, Hyo Jeong Kim, Young Jin Choi, et al.
Journal of Pain and Symptom Management|August 24, 2019
Efficacy of a Decision Aid Consisting of a Video and Booklet on Advance Care Planning for Advanced Cancer Patients: Randomized Controlled TrialYoung Ho Yun, EunKyo Kang, Sohee Park, et al.
Pageof 11